GSK delivers Q3 earnings beat, reaffirms 2026 outlook (GSK:NYSE)
· seekingalpha.com
GSK beats Q3 EPS estimates as specialty medicines drive growth despite vaccine weakness.
GSK plc (GSK) reported third-quarter core earnings per share above analyst expectations on Wednesday, as growth in specialty medicines helped offset weakness in...